Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Dose dependent, new onset QTc prolongation in a patient with paranoid schizophrenia receiving Clozapine.

Sharma TR, Chahil R.

Asian J Psychiatr. 2011 Sep;4(3):221-2. doi: 10.1016/j.ajp.2011.06.005. Epub 2011 Aug 27. No abstract available.

PMID:
23051123
2.

Sex difference in QTc prolongation in chronic institutionalized patients with schizophrenia on long-term treatment with typical and atypical antipsychotics.

Yang FD, Wang XQ, Liu XP, Zhao KX, Fu WH, Hao XR, Zhang XL, Huang GS, Qu SC, Bai JS, Huang XF, Kosten TR, Zhang XY.

Psychopharmacology (Berl). 2011 Jul;216(1):9-16. doi: 10.1007/s00213-011-2188-5. Epub 2011 Feb 9.

PMID:
21301815
3.

QTc prolongation in schizophrenia patients in Asia: clinical correlates and trends between 2004 and 2008/2009.

Xiang YT, Chiu HF, Ungvari GS, Correll CU, Lai KY, Wang CY, Si TM, Lee EH, He YL, Yang SY, Chong MY, Kua EH, Fujii S, Sim K, Yong MK, Trivedi JK, Chung EK, Udomratn P, Chee KY, Sartorius N, Tan CH, Shinfuku N.

Hum Psychopharmacol. 2015 Mar;30(2):94-9. doi: 10.1002/hup.2458. Epub 2015 Jan 22.

PMID:
25611192
4.

QTc prolongation: is clozapine safe? Study of 82 cases before and after clozapine treatment.

Grande I, Pons A, Baeza I, Torras Á, Bernardo M.

Hum Psychopharmacol. 2011 Aug;26(6):397-403. doi: 10.1002/hup.1221. Epub 2011 Aug 9.

PMID:
21826738
5.

Augmentation of clozapine with ziprasidone in refractory schizophrenia: a double-blind, placebo-controlled study.

Muscatello MR, Pandolfo G, Micò U, Lamberti Castronuovo E, Abenavoli E, Scimeca G, Spina E, Zoccali R, Bruno A.

J Clin Psychopharmacol. 2014 Feb;34(1):129-33. doi: 10.1097/JCP.0000000000000042.

PMID:
24145221
6.

Investigation of the potential of clozapine to cause torsade de pointes.

Warner B, Hoffmann P.

Adverse Drug React Toxicol Rev. 2002;21(4):189-203. Review.

PMID:
12503253
7.

QTc prolongation and clozapine: fact or artefact?

Nielsen J.

Aust N Z J Psychiatry. 2012 Aug;46(8):793-4. doi: 10.1177/0004867412444625. Epub 2012 Apr 4. No abstract available.

PMID:
22492267
8.

Clozapine rechallenge following QTc prolongation.

Law D, Mohan T, Bastiampillai T, Dhillon R.

Aust N Z J Psychiatry. 2014 Feb;48(2):198-9. doi: 10.1177/0004867413498273. Epub 2013 Jul 23. No abstract available.

PMID:
23881080
9.

Social anxiety and premorbid personality disorders in paranoid schizophrenic patients treated with clozapine.

Pallanti S, Quercioli L, Pazzagli A.

CNS Spectr. 2000 Sep;5(9):29-43.

PMID:
17637578
10.

Gender-specific differences in susceptibility to low-dose methadone-associated QTc prolongation in patients with heroin dependence.

Chang KC, Huang CL, Liang HY, Chang SS, Wang YC, Liang WM, Lane HY, Chen CH, Stephen Huang SK.

J Cardiovasc Electrophysiol. 2012 May;23(5):527-33. doi: 10.1111/j.1540-8167.2011.02231.x. Epub 2011 Dec 2.

PMID:
22136144
11.

Electrocardiographic abnormalities in patients treated with clozapine.

Kang UG, Kwon JS, Ahn YM, Chung SJ, Ha JH, Koo YJ, Kim YS.

J Clin Psychiatry. 2000 Jun;61(6):441-6.

PMID:
10901343
12.

[Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].

Ames D, Camm J, Cook P, Falkai P, Gury C, Hurley R, Johnson G, Piepho R, Vieweg V; Cardiac Safety in Schizophrenia Group.

Encephale. 2002 Nov-Dec;28(6 Pt 1):552-62. French.

PMID:
12506268
13.

Methadone Therapy in Underserved Urban Community: QTc Prolongation and Life-Threatening Ventricular Arrhythmias.

Chowdhury M, Wong J, Cheng A, Khilkin M, Palma E.

Cardiovasc Ther. 2015 Jun;33(3):127-33. doi: 10.1111/1755-5922.12120.

PMID:
25825202
14.

Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.

Anchersen K, Clausen T, Gossop M, Hansteen V, Waal H.

Addiction. 2009 Jun;104(6):993-9. doi: 10.1111/j.1360-0443.2009.02549.x. Epub 2009 Apr 9.

PMID:
19392907
15.

Possible association of QTc interval prolongation with co-administration of quetiapine and lovastatin.

Furst BA, Champion KM, Pierre JM, Wirshing DA, Wirshing WC.

Biol Psychiatry. 2002 Feb 1;51(3):264-5.

PMID:
11839370
16.

[A rare and not very studied disorder: childhood-onset schizophrenia. A case report].

Bailly D, de Chouly de Lenclave MB.

Encephale. 2004 Nov-Dec;30(6):540-7. French.

PMID:
15738856
17.

[Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia].

Lü LX, Guo SQ, Chen W, Li Q, Cheng J, Guo JH.

Di Yi Jun Yi Da Xue Xue Bao. 2004 Nov;24(11):1251-4. Chinese.

18.

Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy.

Roy AK, McCarthy C, Kiernan G, McGorrian C, Keenan E, Mahon NG, Sweeney B.

Addiction. 2012 Jun;107(6):1132-9. doi: 10.1111/j.1360-0443.2011.03767.x. Epub 2012 Feb 28.

PMID:
22168435
19.

Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.

Haddad PM, Anderson IM.

Drugs. 2002;62(11):1649-71. Review.

PMID:
12109926
20.

Very high-dose clozapine and electroconvulsive therapy combination treatment in a patient with schizophrenia.

Keller S, Drexler H, Lichtenberg P.

J ECT. 2009 Dec;25(4):280-1. doi: 10.1097/YCT.0b013e3181a2f867.

PMID:
19440159

Supplemental Content

Support Center